These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27979585)

  • 1. The differential expression of protease activated receptors contributes to functional differences between dark and fair keratinocytes.
    Xue M; Lin H; Zhao R; Liang HP; Jackson C
    J Dermatol Sci; 2017 Mar; 85(3):178-185. PubMed ID: 27979585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor 1 and 2 contribute to angiotensin II-induced activation of adventitial fibroblasts from rat aorta.
    He RQ; Tang XF; Zhang BL; Li XD; Hong MN; Chen QZ; Han WQ; Gao PJ
    Biochem Biophys Res Commun; 2016 Apr; 473(2):517-23. PubMed ID: 27012211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells.
    Tripathi T; Abdi M; Alizadeh H
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3912-21. PubMed ID: 24876278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAR1- and PAR2-induced innate immune markers are negatively regulated by PI3K/Akt signaling pathway in oral keratinocytes.
    Rohani MG; DiJulio DH; An JY; Hacker BM; Dale BA; Chung WO
    BMC Immunol; 2010 Oct; 11():53. PubMed ID: 21029417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
    Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
    Huang SC
    Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
    McCoy KL; Traynelis SF; Hepler JR
    Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated Protein C Protects against Murine Contact Dermatitis by Suppressing Protease-Activated Receptor 2.
    Xue M; Lin H; Zhao R; Fryer C; March L; Jackson CJ
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
    Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.
    Feistritzer C; Lenta R; Riewald M
    J Thromb Haemost; 2005 Dec; 3(12):2798-805. PubMed ID: 16359518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
    Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
    Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
    Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.
    Versteeg HH; Schaffner F; Kerver M; Ellies LG; Andrade-Gordon P; Mueller BM; Ruf W
    Cancer Res; 2008 Sep; 68(17):7219-27. PubMed ID: 18757438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells.
    Fang Y; Ferrie AM
    BMC Cell Biol; 2007 Jun; 8():24. PubMed ID: 17587449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and activation of protease-activated receptor-2 correlate with skin color.
    Babiarz-Magee L; Chen N; Seiberg M; Lin CB
    Pigment Cell Res; 2004 Jun; 17(3):241-51. PubMed ID: 15140069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
    Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC
    Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1437-47. PubMed ID: 16079188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAR
    Grisaru-Granovsky S; Kumar Nag J; Zakar L; Rudina T; Lal Gupta C; Maoz M; Kozlova D; Bar-Shavit R
    FASEB J; 2020 Dec; 34(12):15701-15717. PubMed ID: 33136328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.
    Ungefroren H; Gieseler F; Kaufmann R; Settmacher U; Lehnert H; Rauch BH
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C.
    Xue M; Campbell D; Sambrook PN; Fukudome K; Jackson CJ
    J Invest Dermatol; 2005 Dec; 125(6):1279-85. PubMed ID: 16354200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.